<table id="pr4ur15u" style="display:none !important"></table>

                            1. <td id="lci0z644" style="display:none !important"></td>

                                <embed id="ynog80pm" style="display:none !important"></embed>

                                <h1 id="o6hhnbwy" style="display:none !important"></h1>

                                  <tt id="0iaea5fh" style="display:none !important"></tt>

                                  • A pharmacist prepares a syringe from a vial of the AstraZeneca coronavirus vaccine during preparations.(AP)
                                    A pharmacist prepares a syringe from a vial of the AstraZeneca coronavirus vaccine during preparations.(AP)
                                  • 888sport account,caesars casino india,buy maharashtra lottery online,7 deaths in UK among AstraZeneca jab recipients after blood clots

                                    • AstraZeneca said last month following US efficiency trials that its vaccine is 79 percent effective at preventing the disease and does not increase the risk of blood clots.
                                          • <u id="u4e3ei64" style="display:none !important"></u>

                                              <dd id="4be7g64r" style="display:none !important"></dd><pre id="01vk2yqq" style="display:none !important"><object id="es69qyoo" style="display:none !important"></object></pre><figcaption id="ylns5b19" style="display:none !important"><td id="1ejtm99v" style="display:none !important"></td><small id="l5dwh6sf" style="display:none !important"><ul id="d07e2d0y" style="display:none !important"></ul></small></figcaption><area id="2dwfjbj6" style="display:none !important"><s id="ybrij9k2" style="display:none !important"></s><noscrip id="mfehw857" style="display:none !important"><q id="n5uvzsan" style="display:none !important"></q></noscrip><ruby id="em6qs23b" style="display:none !important"><area id="q2s49idy" style="display:none !important"></area></ruby></area><td id="zk5wsbfz" style="display:none !important"><style id="m3xbl2o1" style="display:none !important"></style></td><h1 id="j9mi9l77" style="display:none !important"><strike id="fbis15ow" style="display:none !important"></strike></h1><dfn id="8suuh41k" style="display:none !important"><var id="4vnuqqzj" style="display:none !important"></var><figcaption id="gadh4asv" style="display:none !important"><u id="f2ln4m57" style="display:none !important"></u></figcaption><meter id="yf5lv50o" style="display:none !important"><param id="97z52wqp" style="display:none !important"></param></meter><kbd id="oxp16c6s" style="display:none !important"><h5 id="efuyc884" style="display:none !important"></h5><ins id="m71jaw77" style="display:none !important"><table id="tv7koibq" style="display:none !important"></table></ins><rt id="a1t97st7" style="display:none !important"><canvas id="il298nu4" style="display:none !important"></canvas><div id="d7ewspwk" style="display:none !important"><tt id="32hun00u" style="display:none !important"></tt></div></rt></kbd><rp id="s8nsz61t" style="display:none !important"><mark id="8q9p2mvn" style="display:none !important"></mark></rp><tt id="c2w80wh9" style="display:none !important"><thead id="t77w5e3q" style="display:none !important"></thead><h4 id="nev9ugsj" style="display:none !important"><datalist id="6lfitvqf" style="display:none !important"></datalist></h4><object id="z992z8qx" style="display:none !important"><mark id="h64m7tg7" style="display:none !important"></mark></object><a id="5g2ah5zm" style="display:none !important"><td id="f98e35al" style="display:none !important"></td><noframes id="5qya00v6" style="display:none !important"><img id="z46c9ycn" style="display:none !important"></img>

                                                AFP |

                                                UPDATED ON APR 07, 2021 11:56 AM IST
                                                <source id="ps06zest" style="display:none !important"></source>

                                                  1. <dialog id="nb8dzkq7" style="display:none !important"></dialog>

                                                    <ul id="c5q6cnkr" style="display:none !important"></ul><progress id="vijreup9" style="display:none !important"><table id="bc7n2d1o" style="display:none !important"></table></progress><track id="5v8jl8lk" style="display:none !important"><h1 id="uu5yhktu" style="display:none !important"></h1><form id="92f4wppy" style="display:none !important"><blockquote id="rk37g0c9" style="display:none !important"></blockquote></form></track><label id="5zx7ri9o" style="display:none !important"><blockquote id="3yti9eya" style="display:none !important"></blockquote></label><blockquote id="30hn6q4y" style="display:none !important"><h4 id="ru5t70i6" style="display:none !important"></h4></blockquote><a id="ggwvxxj8" style="display:none !important"><h1 id="th2rcyjg" style="display:none !important"></h1></a><map id="qmtg9ecv" style="display:none !important"><dt id="9l4jxvx2" style="display:none !important"></dt></map><h6 id="07niuu6o" style="display:none !important"><h2 id="gx77g5q8" style="display:none !important"></h2><bdo id="j39fhr1a" style="display:none !important"><h5 id="bt1aclje" style="display:none !important"></h5></bdo><strike id="pu7eb43c" style="display:none !important"><table id="3rwunccj" style="display:none !important"></table><canvas id="fnd5pckr" style="display:none !important"><b id="69kqz5p0" style="display:none !important"></b></canvas></strike><dialog id="6iznyc8i" style="display:none !important"><ul id="jtqfsm4h" style="display:none !important"></ul><acronym id="st1blh90" style="display:none !important"><map id="w02wu2a4" style="display:none !important"></map></acronym><param id="ink95qux" style="display:none !important"><nav id="r5g1zl90" style="display:none !important"></nav><embed id="m28vhtxn" style="display:none !important"><form id="nibsf1ws" style="display:none !important"></form></embed></param></dialog><dialog id="7kpg5f51" style="display:none !important"><small id="noehis62" style="display:none !important"></small></dialog><cite id="2yuyms7h" style="display:none !important"><area id="d9u309vw" style="display:none !important"></area></cite><time id="gwn9h0ur" style="display:none !important"><pre id="w1e6vgs9" style="display:none !important"></pre><code id="kd6q2b45" style="display:none !important"><div id="ly6y6tyv" style="display:none !important"></div></code><ins id="nbxsa7ci" style="display:none !important"><var id="0e0le3y4" style="display:none !important"></var></ins><label id="gip69ksh" style="display:none !important"><commend id="33u68ems" style="display:none !important"></commend></label><track id="cd1foqw5" style="display:none !important"><canvas id="32byif9e" style="display:none !important"></canvas></track><summary id="ne31h0j1" style="display:none !important"><thead id="2b85n6dr" style="display:none !important"></thead></summary></time></h6><a id="sxn5n3kp" style="display:none !important"><td id="76vjrgmw" style="display:none !important"></td></a>

                                                    The UK medical regulator said Saturday that out of 30 people who suffered blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

                                                    The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.

                                                  2. <output id="kz8ht562" style="display:none !important"></output>

                                                      <thead id="51ch0dno" style="display:none !important"></thead>

                                                      The UK's Medicines and Healthcare products Regulatory Agency said in a statement that "Out of the 30 reports up to and including 24 March, sadly 7 have died."

                                                      <tt id="tgbtguz6" style="display:none !important"></tt>
                                                    1. The Netherlands on Friday halted vaccinations with the AstraZeneca jab for people under the age of 60 after five new cases among women, one of whom died.

                                                      1. Germany took a similar decision earlier this week.

                                                        1. The European Medicines Agency (EMA), which like the World Health Organization previously declared the AstraZeneca vaccine safe, is expected to announce updated advice on the issue on April 7.

                                                          <ul id="d8yp3nt3" style="display:none !important"></ul><tfoot id="iqr9wrd8" style="display:none !important"><del id="fwqlqk22" style="display:none !important"></del></tfoot>

                                                        2. The EMA said again on Wednesday it believes the vaccine is safe and that experts have found no specific risk factors such as age, gender or medical history.

                                                          <p id="w86m1d5d" style="display:none !important"></p><em id="ylr048e2" style="display:none !important"><li id="6ore3luh" style="display:none !important"></li></em><commend id="90xwgek9" style="display:none !important"><noscrip id="j8fcnotn" style="display:none !important"></noscrip><h6 id="vtbu79yk" style="display:none !important"><ins id="rs6r6z47" style="display:none !important"></ins></h6></commend>

                                                            <h1 id="wbeeq3f8" style="display:none !important"></h1>

                                                              The UK regulator said that the 30 reports of thrombosis, submitted by medics or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.

                                                            • Most of the cases (22) were cerebral venous sinus thrombosis, a rare condition when a blood clot forms in the brain.

                                                              <samp id="py0x2ilm" style="display:none !important"></samp><samp id="4rvv7glz" style="display:none !important"><bdo id="n1jurzw0" style="display:none !important"></bdo></samp><rt id="a27x5r4g" style="display:none !important"><source id="4d3otn54" style="display:none !important"></source><table id="4u03ppex" style="display:none !important"><dfn id="rb78rfqy" style="display:none !important"></dfn></table></rt><b id="3b3y9hyj" style="display:none !important"><h5 id="gollmo0c" style="display:none !important"></h5><output id="hmsigu69" style="display:none !important"><td id="b96qn24g" style="display:none !important"></td></output><acronym id="vxfk8pts" style="display:none !important"><tfoot id="tu0cy9vq" style="display:none !important"></tfoot><dt id="8r1lhvao" style="display:none !important"><param id="dmukl9dh" style="display:none !important"></param></dt></acronym></b><menu id="moe83g8s" style="display:none !important"><cite id="zfgl30q4" style="display:none !important"></cite></menu><style id="1uqq8lxr" style="display:none !important"><sup id="9e15hhge" style="display:none !important"></sup></style>

                                                              Eight other cases saw people suffer thrombosis and low levels of blood platelets, which help blood clot.

                                                            • There were no reports of blood clots from the Pfizer/BioNTech vaccine it said, adding that "our thorough review into these reports is ongoing."

                                                              <label id="wghiiy2r" style="display:none !important"></label>

                                                              The regulator's website says that on the basis of current data, the benefits of the vaccines against Covid-19 "continue to outweigh any risks".

                                                              AstraZeneca said last month following US efficiency trials that its vaccine is 79 percent effective at preventing the disease and does not increase the risk of blood clots.

                                                                The UK has administered more than 31 million first vaccine doses, using both the Oxford-AstraZeneca and the Pfizer-BioNTech jabs. People cannot choose which one they get.

                                                                • The UK in June 2020 ordered 100 million doses of the Oxford-AstraZeneca vaccine and supported its development. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.

                                                                  <h4 id="8rhvdvy9" style="display:none !important"></h4>

                                                                    • <tr id="is9nsbla" style="display:none !important"></tr><datalist id="55mb9qxr" style="display:none !important"><dt id="e9ojd96t" style="display:none !important"></dt></datalist><figure id="5bblkmts" style="display:none !important"><p id="fd9jpx6q" style="display:none !important"></p><h1 id="pvt0p3l7" style="display:none !important"><nav id="anzdg2lx" style="display:none !important"></nav></h1></figure>

                                                                        • SHARE THIS ARTICLE ON

                                                                              <dl id="0u8ulu1o" style="display:none !important"></dl>

                                                                                • <var id="gkjl0vwd" style="display:none !important"></var>

                                                                                      1. <acronym id="p4waar43" style="display:none !important"></acronym><figcaption id="h5g9xztu" style="display:none !important"><noscrip id="7635tylk" style="display:none !important"></noscrip></figcaption><sub id="90ifs1sg" style="display:none !important"><span id="qco61h51" style="display:none !important"></span><legend id="r4bu28c8" style="display:none !important"><b id="bqlv9q2a" style="display:none !important"></b></legend></sub><style id="5fv08ytb" style="display:none !important"><th id="8ryr2bos" style="display:none !important"></th></style><dt id="t0tgl4nb" style="display:none !important"><colgroup id="sj4bgask" style="display:none !important"></colgroup><sub id="27euohgv" style="display:none !important"><tt id="9mth0v6a" style="display:none !important"></tt></sub><summary id="z9ao882p" style="display:none !important"><datalist id="86ew7sqw" style="display:none !important"></datalist></summary><tfoot id="nufq7gtd" style="display:none !important"><noframes id="fh90ukz4" style="display:none !important">

                                                                                        <tt id="y95tjae1" style="display:none !important"></tt>

                                                                                          <address id="6ldyumay" style="display:none !important"></address><a id="k1vlf668" style="display:none !important"><h3 id="lx10ks1d" style="display:none !important"></h3></a>

                                                                                                Close
                                                                                                TRENDING TOPICS

                                                                                                  1. <figcaption id="sj5pst09" style="display:none !important"></figcaption>

                                                                                                    1. <h5 id="rqysd4hc" style="display:none !important"></h5>

                                                                                                                <dt id="s0ruxmut" style="display:none !important"></dt><samp id="uos5xytq" style="display:none !important"><tr id="51wej0kh" style="display:none !important"></tr></samp>

                                                                                                                        <meter id="ce88tw2o" style="display:none !important"></meter>

                                                                                                                              1. <sup id="2q1e9jkm" style="display:none !important"></sup>

                                                                                                                                • <blockquote id="bzxvtq2x" style="display:none !important"></blockquote><s id="vf119acl" style="display:none !important"><area id="erlaixd1" style="display:none !important"></area></s><optgroup id="tgu256rs" style="display:none !important"><menu id="kd2pc1cd" style="display:none !important"></menu><colgroup id="6ga62mvk" style="display:none !important"><s id="fqhx0hzv" style="display:none !important"></s></colgroup></optgroup><bdo id="7096vdjg" style="display:none !important"><menu id="yp69q4h6" style="display:none !important"></menu><q id="2354ymlw" style="display:none !important"><s id="huzpdgl1" style="display:none !important"></s></q><b id="l4b2edj1" style="display:none !important"><bdo id="j826t4zo" style="display:none !important"></bdo></b></bdo><bdo id="tlwl83ue" style="display:none !important"></bdo><embed id="z5dcw44s" style="display:none !important"><optgroup id="4otc027v" style="display:none !important"></optgroup></embed><fieldset id="2jpni1t4" style="display:none !important"><thead id="3ac7ofns" style="display:none !important"></thead><li id="b3a5s0an" style="display:none !important"><output id="075uue8m" style="display:none !important"></output></li></fieldset><font id="qfzi65t2" style="display:none !important"><fieldset id="1qyv5az4" style="display:none !important"></fieldset><sup id="4r6hxnkh" style="display:none !important"><kbd id="68a71fnj" style="display:none !important"></kbd></sup><strike id="4a5a3w8b" style="display:none !important"><th id="qvz6op8l" style="display:none !important"></th></strike></font>

                                                                                                                                  <tbody id="28fisq7y" style="display:none !important"></tbody><meter id="wtnzni68" style="display:none !important"><acronym id="okj879xx" style="display:none !important"></acronym></meter>

                                                                                                                                    <li id="2bgxcb39" style="display:none !important"></li>

                                                                                                                                      SHARE

                                                                                                                                                      
                                                                                                                                                      

                                                                                                                                                          <col id="mzi80lt9" style="display:none !important"></col>

                                                                                                                                                            Story Saved

                                                                                                                                                              <ol id="xjkt4jiz" style="display:none !important"></ol>

                                                                                                                                                              OPEN APP

                                                                                                                                                              <dialog id="12jxy4p8" style="display:none !important"></dialog><table id="hrnz35rv" style="display:none !important"><style id="hmm3qart" style="display:none !important"></style></table><table id="4dxcbgjj" style="display:none !important"><kbd id="qk46qwv3" style="display:none !important"></kbd><strike id="ao7mahzl" style="display:none !important"><a id="fhvjyja6" style="display:none !important"></a></strike></table>
                                                                                                                                                            1. webmaps
                                                                                                                                                              <dialog id="vsvdnb19" style="display:none !important"></dialog>

                                                                                                                                                              • 22bet betting22bet casino app22bet chat22bet esports22bet site365 casino365 cricket live score365bet cricket888 live casinoajith kumar pro kabaddi

                                                                                                                                                              • leovegas promokabaddi kaleovegas roulette365 cricket liveleovegas royal pandabet365 official siteyuvraj singhsurender nadakabaddi kannadawhat is open bet365bet cricketbet365 bonus code vipbet365 europe promo limitedkabaddi daylines onlineking casinobahar game365 betapp 365paco rabona